Roche Holding AG (OTCQX International Premier:RHHVF)

242.44
Delayed Data
As of Feb 16
 -0.75 / -0.31%
Today’s Change
227.00
Today|||52-Week Range
276.80
-3.41%
Year-to-Date
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock (Revised)
Feb 16 / Zacks.com - Paid Partner Content
ImmunoGen (IMGN) Q4 Loss Wider Than Expected, Revenues Grow
Feb 12 / Zacks.com - Paid Partner Content
Roche (RHHBY) to Acquire Flatiron Health for $1.9 Billion
Feb 16 / Zacks.com - Paid Partner Content
Will Prothena (PRTA) Disappoint Investors in Q4 Earnings?
Feb 09 / Zacks.com - Paid Partner Content
AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan
Feb 16 / Zacks.com - Paid Partner Content
Biogen Halts Tysabri Development in Stroke as Study Fails
Feb 08 / Zacks.com - Paid Partner Content
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock
Feb 15 / Zacks.com - Paid Partner Content
Seattle Genetics (SGEN) Q4 Earnings & Revenues Top Estimates
Feb 07 / Zacks.com - Paid Partner Content
Prothena's (PRTA) Loss Narrows in Q4, Pipeline Progresses
Feb 15 / Zacks.com - Paid Partner Content
Array's Melanoma Combo Shows Positive Overall Survival Data
Feb 07 / Zacks.com - Paid Partner Content
Roche's Rituxan Gets Priority Review for Label Expansion
Feb 14 / Zacks.com - Paid Partner Content
Top Analyst Reports for Apple, Visa, Chevron & Altria
Feb 06 / Zacks.com - Paid Partner Content
Exelixis Reports Positive Data From Thyroid Carcinoma Trial
Feb 14 / Zacks.com - Paid Partner Content
Roche Reports Positive Data From Tecentriq-Avastin Study
Feb 06 / Zacks.com - Paid Partner Content
Can ImmunoGen's Key Ovarian Cancer Candidate Drive Growth?
Feb 14 / Zacks.com - Paid Partner Content
Is a Beat in the Cards for ImmunoGen (IMGN) in Q4 Earnings?
Feb 05 / Zacks.com - Paid Partner Content
Pfizer Announces FDA Acceptance of NDA for NSCLC Candidate
Feb 13 / Zacks.com - Paid Partner Content
Foreign Stock Roundup: RDS.A & AZN Impress, NVO & BABA Disappoint
Feb 05 / Zacks.com - Paid Partner Content